Investors

Overview

Syngene International Limited is an integrated research, development and manufacturing organisation providing scientific services – from early discovery to commercial supply. We offer services across wide range of sectors including pharmaceutical, nutrition, animal health, consumer goods and speciality chemical companies.

Our long-term collaborations ensures predictable and stable cash flows. Our strong balance sheet and financial performance has helped us in reassuring clients that we will be able to support their investments in terms of both capabilities and capacities.

Our ability to make these investments helps strengthen trust and engagement with our clients, which enhances our ability to retain them and extend our engagement across multiple platforms.

Corporate Governance

View our Corporate Governance policies and reports

Financial Reports & Filings

View our complete financial highlights from FY 2016 till date

Annual Report 2020

View the interactive version of our current annual report

Share Holder Services

View details of our Shareholder Services

Share Holder
Services

View details of our Shareholder Services

Corporate
Governance

View our Corporate Governance policies and reports

Financial
Information

View our complete financial highlights from FY 2016 till date

Investor
Fact Sheet

View our investor fact sheet

Analyst
Coverage

View the list of analysts covering Syngene

Annual Report
2020

View the interactive version of our current annual report

View Stock Information

View Stock Information

Awards and Recognitions

At Syngene, we aim to contribute to the evolution of scientific research using our skills, technology and experience to find solutions to the world’s most complex challenges.

Syngene & Deerfield – Financial Times

Syngene and Deerfield Discovery and Development (3DC) sign 5-year strategic collaboration

Investor Calendar

Conference Call For Analysts And Investors